Croda opens advanced lipids manufacturing facility in Pennsylvania
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
The project will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines
Construction will begin this year with the new capacity anticipated by 2025
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
This clinical study will inform operational logistics and use of AV7909 should an anthrax emergency occur.
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
Subscribe To Our Newsletter & Stay Updated